Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2023-10-31 | 2023-06-16 |
| Drug Identification Number | 02198630 | 02198630 |
| Brand name | CALMYLIN ACE | CALMYLIN ACE |
| Common or Proper name | CALMYLIN ACE | CALMYLIN ACE |
| Company Name | TEVA CANADA LIMITED | TEVA CANADA LIMITED |
| Ingredients | CODEINE PHOSPHATE PHENIRAMINE MALEATE GUAIFENESIN | CODEINE PHOSPHATE PHENIRAMINE MALEATE GUAIFENESIN |
| Strength(s) | 10MG 7.5MG 100MG | 10MG 7.5MG 100MG |
| Dosage form(s) | SYRUP | SYRUP |
| Route of administration | ORAL ORAL | ORAL ORAL |
| Packaging size | 500ML | 500ML |
| ATC code | R05FA | R05FA |
| ATC description | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS | COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2023-06-16 | 2023-06-16 |
| Estimated end date | 2023-10-30 | 2023-10-20 |
| Actual end date | 2023-10-30 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | OTC not reported on DS | |
| Health Canada comments |